Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




NY Course 2008: HIV Pathogenesis and Prevention
Link ID 6205
Title NY Course 2008: HIV Pathogenesis and Prevention
Url http://www.medscape.com/viewprogram/14605?src=rss
Description Drs. Lederman and Herold review HIV pathogenesis and continuing efforts to develop an effective microbicide against HIV infection in their talks from HIV Management 2008: The New York Course. Medscape HIV/AIDS
Category Articles > Allergy and Clinical Immunology
Keywords
Date May 31, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. FDA Approvals: Moxatag, Welchol, Sular
  The FDA has approved amoxicillin extended-release tablets (Moxatag), a new indication for colesevelam tablets (Welchol), and newly formulated nisoldipine extended-release tablets (Sular). Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


2. Uric Acid Triggers Innate Immune Response
  Uric acid, an endogenous danger signal released by dying cells, may be involved in the autoimmune response by supplying a signal that leads to enhanced antibody immunity. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


3. ACAAI 2008: Skin Test May Be Good Negative Predictor for Anesthetic Allergy
  Of the patients who tested negative for local anesthetic allergy, 97% also tested negative by subcutaneous challenge. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


4. Therapeutic Options for Pediatric Atopic Dermatitis Reviewed
  A review offers therapeutic options for treating atopic dermatitis in children and discusses the differences between topical corticosteroids and topical calcineurin inhibitors. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


5. Adjuvanted H5N1 Influenza Vaccine Shows Promise
  A novel adjuvanted, low-dose influenza A (H5N1) vaccine candidate is safe and immunogenic in healthy adults, according to a report in the September 1st issue of The Journal of Infectious Diseases. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS